Adaptive Biotechnologies: Q3 Earnings Snapshot
SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Thursday reported a loss of $50.3 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 35 cents.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The life-sciences research company posted revenue of $37.9 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $43.3 million.
In the final minutes of trading on Thursday, the company's shares hit $4.32. A year ago, they were trading at $7.25.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT
